Startle and sensorimotor gating in rats lacking CCK-A receptors

Neuropsychopharmacology

Volumn 24, Issue 6, 2001, Pages 663-670

  Feifel, David ^a   Priebe, Kristianne ^a   Shilling, Paul D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amphetamine; Apomorphine; CCK; CCK A; Cholecystokinin; Dizocilpine; Haloperidol; LETO; Locomotor activity; OLETF; Prepulse inhibition; Schizophrenia; Startle

Indexed keywords

AMPHETAMINE; APOMORPHINE; CHOLECYSTOKININ A RECEPTOR; DIZOCILPINE; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FACILITATION; GENOTYPE; LOCOMOTION; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; RAT STRAIN; SENSORIMOTOR FUNCTION; STARTLE REFLEX; STRAIN DIFFERENCE; TREATMENT OUTCOME;

ACOUSTIC STIMULATION; AMPHETAMINE; ANIMALS; APOMORPHINE; BRAIN; CHOLECYSTOKININ; DIZOCILPINE MALEATE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; HALOPERIDOL; MALE; MOTOR ACTIVITY; NEURAL INHIBITION; RATS; RATS, INBRED OLETF; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ; STARTLE REACTION;

EID: 0035014138     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00235-9     Document Type: Article

References (45)

1. Acri J.B., Brown K.J., Saah M.I., Grunberg N.E. Strain and age differences in acoustic startle responses and effects of nicotine in rats. Pharmacol Biochem Behav. 50:1995;191-198.
2. al-Amin H.A., Schwarzkopf S.B. Effects of the PCP analog dizocilpine on sensory gating. potential relevance to clinical subtypes of schizophrenia Bio Psychiatry. 40:1996;744-754.
3. Bakshi V.P., Geyer M.A. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology. 122:1995;198-201.
4. Bakshi V.P., Geyer M.A. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist. J Pharmacol Exp Ther. 283:1997;666-674.
5. Bakshi V.P., Swerdlow N.R., Geyer M.A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther. 271:1994;787-794.
6. Braff D.L., Geyer M. Sensorimotor gating and schizophrenia. Human and animal model studies Arch Gen Psych. 47:1990;181-188.
7. Crawley J. Cholecystokinin-dopamine interactions. TINS. 165:1991;6147-6151.
8. Crawley J.N. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway. J Neurosci. 12:1992;3380-3391.
9. Depoortere R., Perrault G., Sanger D.J. Potentiation of prepulse inhibition of the startle reflex in rats. Pharmacological evaluation of the procedure as a model for detecting antipsychotic activity Psychopharmacology. 132:1997;366-374.
10. Feifel D. Individual differences in prepulse inhibition of startle as a measure of individual dopamine function. Behavior Neurosci. 113:1999;1020-1029.
11. Feifel D., Reza T. Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating. Psychopharmacology. 141:1999;93-98.
12. Feifel D., Reza T.L., Robeck S.L. Antipsychotic potential of CCK-based treatments. An assessment using the prepulse inhibition model of psychosis Neuropsychopharmacology. 20:1999;141-149. a.
13. Feifel D., Reza T.L., Wustrow D.J., Davis M.D. Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist. J Pharmacol Exp Ther. 288:1999;710-713. b.
14. Feifel D., Swerdlow N. The modulation of sensorimotor gating deficits by mesolimbic cholecystokinin. Neurosci Let. 229:1997;5-8.
15. Fendt M., Koch M., Kungel M., Schnitzler H. Cholecystokinin enhances the acoustic startle response in rats. Neuroreport. 6:1995;2081-2084.
16. Funakoshi A., Miyasaka K., Shinozaki H., Masuda M., Kawanami T., Takata Y., Kono A. An animal model of congenital defect of gene expression of cholecystokinin (CCK)-A receptor. Biochem Biophys Res Com. 210:1995;787-796.
17. Furuya Y., Kagaya T., Ogura H., Nishizawa Y. Competitive NMDA receptor antagonists disrupt prepulse inhibition without reduction of startle amplitude in a dopamine receptor-independent manner in mice. Euro J Pharmacol. 364:1999;133-140.
18. Hokfelt T., Skirboll L., Rehfeld J.F., Goldstein M., Markey K. A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contain a cholecystokinin-like peptide. Neuroscience. 5:1980;2093-2124.
19. Johansson C., Jackson D.M., Svensson L. Nitric oxide synthase inhibition blocks phencyclidine-induced behavioral effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacology. 131:1997;167-173.
20. Johansson C., Jackson D.M., Zhang J., Svensson L. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating. Effects of antipsychotics and other agents in rats Pharmacol Biochem Behav. 52:1995;649-654.
21. Josselyn S., Frankland P., Petrisano S., Bush D., Yeomans J., Vaccarino F. The CCKB antagonist, L-365,260, attenuates fear-potentiated startle. Peptides. 16:1995;1313-1315.
22. Kariya K., Tanaka J., Nomura M. Systemic administration of CCK-8S, but not CCK-4, enhances dopamine turnover in the posterior nucleus accumbens. A microdialysis study in freely moving rats Brain Res. 657:1994;1-6.
23. Keith V.A., Mansbach R.S., Geyer M.A. Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biological Psychiatry. 30:1991;557-566.
24. Kihara T., Ikeda M., Matsubara K., Matsushita A. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat. Euro J Pharmacol. 230:1993;271-277.
25. Kinney G.G., Wilkinson L.O., Saywell K.L., Tricklebank M.D. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity. J Neurosci. 19:1999;5644-5653.
26. Kobayashi S., Ohta M., Miyasaka K., Funokoshi A. Decrease in exploratory behavior in naturally occurring cholecystokinin (CCK)-A receptor gene knockout rats. Neurosci Let. 21:1996;61-64.
27. Logue S.F., Owen E.H., Rasmussenn D.L., Wehner J.M. Assessment of locomotor activity, acoustic and tactile startle, and prepulse inhibition of startle in inbred mouse strains and F1 hybrids. implications of genetic background for single gene and quantitative trait loci analyses Neurosci. 80:1997;1075-1086.
28. Otsuki M., Akiyama T., Shirohara H., Nakano S., Furumi K., Tachibana I. Loss of sensitivity to cholecystokinin stimulation of isolated pancreatic acini from genetically diabetic rats. Am J Physiol. 268:1995;E531-E536.
29. Paylor R., Crawley J.N. Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology. 132:1997;169-180.
30. Popoli P., Reggio R., Pèzzola A., Scotti de Carolis A. The stimulation of cholecystokinin receptors in the rostral nucleus accumbens significantly antagonizes the EEG and behavioural effects induced by phencyclidine in rats. Psychopharmacology. 120:1995;156-161.
31. Rigdon G.C. Differential effects of apomorphine on prepulse inhibition of acoustic startle reflex in two rat strains. Psychopharmacology. 102:1990;419-421.
32. Shilling P.D., Feifel D., Kelsoe J.R. Amphetamine-induced zif268 mRNA expression in the medial posterior nucleus accumbens in cholecystokinin-A receptor mutant rats. Neurosci Let. 281:2000;17-20.
33. Sipes T.A., Geyer M.A. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology. 33:1994;441-448.
34. Swerdlow N.R., Braff D., Taiid N., Geyer M.A. Assessing the validity of an animal model of sensorimotor gating deficits in schizophrenia. Arch Gen Psych. 51:1994;139-154.
35. Swerdlow N.R., Bakshi V., Geyer M.A. Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Therap. 279:1996;1290-1299.
36. Swerdlow N.R., Braff D.L., Geyer M.A., Koob G.F. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biological Psychiatry. 21:1986;23-33.
37. Swerdlow N.R., Braff D.L., Masten V.L., Geyer M.A. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology. 101:1990;414-420. a.
38. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophrenia Bulletin. 24:1998;285-301.
39. Swerdlow N.R., Mansbach R.S., Geyer M.A., Pulvirenti L., Koob G.F., Braff D.L. Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology. 100:1990;413-416. b.
40. Swerdlow N.R., Martinez Z.A., Hanlon F.M., Platten A., Farid M., Auerbach P., Braff D.L., Geyer M.A. Toward understanding the biology of a complex phenotype. Rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists J Neurosci. 20:2000;4325-4436.
41. van Megen H.J., Westenberg H.G., den Boer J.A., Kahn R.S. Cholecystokinin in anxiety. European Neuropsychopharmacology. 6:1996;263-280.
42. Varty G.B., Higgins G.A. Examination of drug-induced and isolation-induced disruption of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology. 122:1995;15-26.
43. Walker D.L., Davis M. Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biological Psychiatry. 42:1997;461-471.
44. Wan F.J., Geyer M.A., Swerdlow N.R. Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating. Psychopharmacology. 120:1995;433-441.
45. Zhang J., Engel J.A., Jackson D.M., Johansson C., Svensson L. Alprenolol potentiates the disrupting effects of dizocilpine on sensorimotor function in the rat. Psychopharmacology. 132:1997;281-288.